The short version
13 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Diazepam
Diazepam · DIAZEPAM 10 mg/2mL · Injection, Solution · Intramuscular; Intravenous · Alembic Pharmaceuticals Limited
NDC 46708-0811-20 · 10 SYRINGE, GLASS in 1 CARTON / 2 mL in 1 SYRINGE, GLASS · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $16.24 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA218450
- TE code
- AP
- Approval date
- Apr 25, 2024
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Diazepam (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Natco Pharma USA LLC | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 3, 2026 |
| Remedyrepack Inc. | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 3, 2026 |
| Alembic Pharmaceuticals Inc. | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Civica, Inc. | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Henry Schein, Inc. | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Natco Pharma USA LLC | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hospira, Inc. | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Medical Purchasing Solutions, LLC | DIAZEPAM 5 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| Baxter Healthcare Corporation | DIAZEPAM 20 mg/4mL | Aug 7, 2026 | Aug 28, 2026 |
| Baxter Healthcare Corporation | DIAZEPAM 10 mg/2mL | Aug 7, 2026 | Aug 28, 2026 |
| Dr. Reddy's Laboratories Inc | DIAZEPAM 10 mg/2mL | Jul 15, 2026 | Aug 28, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Diazepam — NDC 46708-0811-20," retrieved September 3, 2026, https://drugdashboards.com/drug/46708081120.
Free to cite with attribution — see how the data is put together.